Demant ASWILLF 90 Days Payable is 59.08 as of Dec. 2025, which is 0% above its 10-year median of 59.06. GuruFocus rates WILLF with a GF Score™ of 90/100 and a GF Value™ of $48.94 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Demant AS ranks worse than 62.64% on this metric.
Demant AS's average Accounts Payable for the
six
months ended in Dec. 2025 was $147 Mil. Demant AS's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $454 Mil.
Hence, Demant AS's Days Payable for the
six
months ended in Dec. 2025 was 59.08.
The historical rank and industry rank for Demant AS's Days Payable or its related term are showing as below:
WILLF'
s Days Payable Range Over the Past 10 Years
Min: 49.9 Med: 59.06 Max: 66.07
Current: 55.29
During the past 13 years, Demant AS's highest Days Payable was 66.07. The lowest was 49.90. And the median was 59.06.
WILLF's Days Payable is ranked worse than 62.64% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs WILLF: 55.29
Demant AS's Days Payable
increased
from Dec. 2024 (51.04) to Dec. 2025 (59.08).
It may suggest that Demant ASdelayed paying its suppliers.
Demant AS Days Payable Related Terms
Demant AS Days Payable Historical Data
* Premium members only.
The historical data trend for Demant AS's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Demant AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Demant AS Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's Days Payable distribution charts can be found below:
* The bar in red indicates where Demant AS's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Demant AS's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Demant AS (WILLF) has a Days Payable of 59.08 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Demant AS and its competitors. This is near median its historical median of 59.06. Over the past decade, Demant AS's Days Payable has ranged from 49.90 to 66.07. According to the industry distribution chart, Demant AS ranks #498 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 62.6%.
Is Demant AS's Days Payable too high?
Demant AS's current Days Payable of 59.08 is near median its 10-year median of 59.06. Over the past 10 years, this metric has ranged from a low of 49.90 to a high of 66.07. The Medical Devices & Instruments industry median Days Payable is 68.07. Demant AS's value of 59.08 is 13.2% below this industry median. Based on the distribution chart, Demant AS ranks #498 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Demant AS has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Demant AS's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Demant AS ranks #498 out of 795 companies for Days Payable. This places Demant AS in the lower half of its industry. The industry median Days Payable is 68.07. Demant AS's value of 59.08 is 13.2% below this benchmark. Historically, Demant AS's own Days Payable has ranged from 49.90 to 66.07 over the past decade. While the company's 10-year median is 59.06 vs. the industry median of 68.07, Demant AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Demant AS's current Days Payable of 59.08 is 13.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Demant AS and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Demant AS's current Days Payable is 59.08, which is near median its own 10-year median of 59.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Demant AS stock overvalued right now?
Based on GuruFocus' analysis, Demant AS (WILLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $48.94, compared to a current price of $40.23 — trading 17.8% below its estimated fair value. The current Days Payable is 59.08, which is near median its 10-year median of 59.06 and 13.2% below the Medical Devices & Instruments industry median of 68.07. Demant AS's overall GF Score™ is 90/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Demant AS (WILLF), the current Days Payable is 59.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Demant AS (WILLF) Overvalued in 2026?
Based on GuruFocus' analysis, Demant AS stock appears to be undervalued.
The current stock price of $40.23 is trading 17.8% below its estimated GF Value™ of $48.94.
GuruFocus considers Demant AS to be Modestly Undervalued.
Key valuation signals for WILLF:
Days Payable: 59.08 (near median its 10-year median of 59.06)
GF Value™: $48.94 vs. price of $40.23 (17.8% below fair value)
Industry Position: 13.2% below the Medical Devices & Instruments median (#498 of 795)
No single metric tells the full story. See the WILLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
90GF Score
Get the complete analysis for WILLF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WILLF has been successfully added to your 
